Attenzione! Per visualizzare al meglio il sito e usufruire di tutte le funzionalità messe a disposizione
si consiglia di aggiornare la versione in uso di Internet Explorer alla versione 8 o superiore. Grazie!

Con il passaggio alla nuova versione
del sito e ad un diverso provider tecnologico, non è più possibile
utilizzare la vecchia utenza/password
di SIN-ITALY.

Coloro che sono registrati su nephroMEET possono accedere a questo nuovo sito utilizzando la stessa utenza e password di nephroMEET.

Se non sei registrato a nephroMEET, ma eri registrato sul sito
SIN-ITALY, clicca qui

Inserisci il tuo codice fiscale e la mail per recuperare i tuoi dati anagrafici ed effettuare il passaggio al nuovo sito:



Abbiamo inviato una e-mail all'indirizzo che ci hai indicato. Accedi alla tua casella di posta e segui le istruzioni inserite nella e-mail per completare il passaggio.

Vol. 4 — July-August 2011

  • Identification of a novel target of thiazide diuretics

    Dominique Eladari1, Régine Chambrey2

    (1) UPMC Universtité Paris 06, INSERM UMRS 872 Team 3 and CNRS ERL7226, Laboratory of renal genomics physiology and pathophysiology, Centre de recherche des Cordeliers, Paris - France and Faculty of Medicine Paris Descartes, University of Paris Descartes, Paris - France and Department of Physiology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris - France
    (2) UPMC Universtité Paris 06, INSERM UMRS 872 Team 3 and CNRS ERL7226, Laboratory of renal genomics physiology and pathophysiology, Centre de recherche des Cordeliers, Paris - France and Faculty of Medicine Paris Descartes, University of Paris Descartes, Paris - France

  • Ultrafiltration intensification for achievement of dry weight and hypertension control is not always the therapeutic gol

    Gèrard M. London1

    (1) INSERM U970, George Pompidou European Hospital, Paris - France

  • Home dialysis first: a new paradigm for new ESRD patients

    Elias D. Thodis1, Dimitrios G. Oreopoulos2

    (1) Division of Nephrology, Medical School, University of Thrace, Alexandroupolis - Greece
    (2) Division of Nephrology , University Network, Toronto, Ontario - Canada

  • The impact of short daily and nocturnal hemodialysis on quality of life, cardiovascular risk and survival

    Bruce F. Culleton1, Markku R. Asola2

    (1) Baxter Inc., Deerfield, Illinois - USA
    (2) Baxter International Inc., Kista - Sweden

  • Inhibitors of vascular calcification as potential therapeutic targets

    Raja Rezg1, Fellype C. Barreto1, Daniela V. Barreto2, Sophie Liabeuf2, Tilman B. Drüeke1, Ziad A. Massy3

    (1) INSERM ERI-12 (EA 4292), Amiens - France
    (2) INSERM ERI-12 (EA 4292), Amiens - France and Clinical Research Centre, Division of Clinical Pharmacology, Amiens University Hospital and the Jules Verne University of Picardy, Amiens - France
    (3) INSERM ERI-12 (EA 4292), Amiens - France and Clinical Research Centre, Division of Clinical Pharmacology, Amiens University Hospital and the Jules Verne University of Picardy, Amiens - France and Division of Nephrology, Amiens University Hospital, Amiens - France

  • Role of the fixed-dose combination lercanidipine–enalapril in renal protection

    Colin Gerard Egan1, Roberto Pontremoli2

    (1) Primula Multimedia S.R.L., Pisa - Italy
    (2) Department of Internal Medicine, University of Genoa, Genoa - Italy

  • Nephrology around Europe: organization models and management strategies: Spain

    Angel L.M. de Francisco1, Celestino Piñera1

    (1) Servicio de Nefrología, Valdecilla Universitary Hospital, Universidad de Cantabria, REDinRed, Santander - Spain

  • Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD

    Pietro Manuel Ferraro1, Monica Bonello1, Alessia Gambaro1, Antonio Sturniolo1, Giovanni Gambaro1

    (1) Division of Nephrology and Dialysis, Department of Internal Medicine and Medical Specialties, Renal Program, Columbus-Gemelli University Hospital, Catholic University of Rome, Rome - Italy

  • Plasma protein carbonylation in chronic uremia

    Barbara Pavone1, Vittorio Sirolli2, Annalisa Giardinelli3, Sonia Bucci3, Federica Forlì3, Moreno Di Cesare2, Paolo Sacchetta4, Natalia Di Pietro3, Assunta Pandolfi3, Andrea Urbani5, Mario Bonomini2

    (1) Aging Research Center, Ce.S.I., G. d’Annunzio University Foundation, Chieti-Pescara - Italy and Department of Biomedical Sciences, G. d’Annunzio University, Chieti-Pescara - Italy and IRCCS-Santa Lucia Foundation, Rome - Italy
    (2) Department of Medicine, G. d’Annunzio University, Chieti-Pescara - Italy
    (3) Aging Research Center, Ce.S.I., G. d’Annunzio University Foundation, Chieti-Pescara - Italy and Department of Biomedical Sciences, G. d’Annunzio University, Chieti-Pescara - Italy
    (4) Department of Biomedical Sciences, G. d’Annunzio University, Chieti-Pescara - Italy
    (5) IRCCS-Santa Lucia Foundation, Rome - Italy and Department of Internal Medicine, Tor Vergata University, Rome - Italy

  • Ultrafiltration intensification in hemodialysis patients improves hypertension but increases AV fistula complications an

    Giuseppe Curatola1, Davide Bolignano1, Stefania Rastelli1, Graziella Caridi1, Rocco Tripepi1, Giovanni Tripepi1, Raffaele Politi1, Francesco Catalano1, Diego Delfino1, Maurizio Ciccarelli1, Francesca Mallamaci1, Carmine Zoccali1

    (1) Nephrology, Dialysis and Renal Transplantation Unit and CNR-IBIM Clinical epidemiology and Pathophysiology of Renal Diseases and Hypertension, United Hospitals, Reggio Calabria - Italy

  • Cyclosporine A causes maturation failure in embryonic-type glomeruli persisting after birth

    Shinsuke Fujita1, Keisuke Sugimoto1, Tomoki Miyazawa1, Kohei Miyazaki1, Yutaka Takemura1, Hidehiko Yanagida1, Naoki Sakata1, Norihisa Wada1, Mitsuru Okada1, Tsukasa Takemura1

    (1) Department of Pediatrics, Kinki University School of Medicine, Osaka-Sayama - Japan

  • Measurement of glomerular filtration rate using dynamic magnetic resonance imaging in patients with chronic kidney disea

    Ferruh Artunc1, Serdar Yildiz2, Andreas Boss3, Thomas Frenzel4,5, Heinz-Peter Schlemmer6, Fritz Schick7, Teut Risler2, Hans-Ulrich Häring8, Cristina Rossi6

    (1) 1 Department of Internal Medicine IV, Section of Nephrology and Hypertension, University of Tuebingen, Tuebingen - Germany
    (2) 1Department of Internal Medicine IV, Section of Nephrology and Hypertension, University of Tuebingen, Tuebingen - Germany
    (3) 2 Department of Radiology, University of Tuebingen, Tuebingen - Germany
    (4) 3 Bayer Schering Pharma AG, Cardiovascular Imaging &
    (5) Contrast Media Research, Berlin - Germany
    (6) 2Department of Radiology, University of Tuebingen, Tuebingen - Germany
    (7) 2Department of Radiology, University of Tuebingen, Tuebingen – Germany
    (8) 1Department of Internal Medicine IV, Section of Nephrology and Hypertension, University of Tuebingen, Tuebingen – Germany

  • L-Carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tis

    Mohamed M. Sayed-Ahmed1

    (1) Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh - Kingdom of Saudi Arabia

  • Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate

    Shaojiang Tian1, Yanjie Gan2, Junfeng Li1, Liping Wang1, Jianming Shen1, Tao Liu1, Tingting Ye1, Huihui Liu1, Dianjun Liu1, Yanyan Deng1, Wei Wang1

    (1) Department of Nephrology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei - PR China
    (2) Department of Cardiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei - PR China

  • Plasma B-type natriuretic peptide in dialyzed patients: marker of cardiovascular disease or link to plasma refilling

    Andreana De Mauri1, Giorgio Bellomo2, Carlo Navino1, Paola David1, Doriana Chiarinotti1, Federica Capurro1, Maddalena Brustia1, Mariangela De Maria1, Carlo Edoardo Ruva1, Laura Ciardi2, Martino De Leo1

    (1) Nephrology and Dialysis Unit, Maggiore della Carità Hospital, Novara, Italy
    (2) Clinical Chemistry Unit, Maggiore della Carità Hospital, Novara, Italy

  • Low-grade albuminuria reduction with angiotensin II type 1 receptor blocker in renal transplant recipients

    Junji Uchida1, Yuichi Machida1, Tomoaki Iwai1, Taro Iguchi1, Yoshiko Kamada1, Toshihide Naganuma1, Norihiko Kumada1, Taku Kim1, Hidenori Kawashima1, Tatsuya Nakatani2

    (1) Department of Urology, Osaka City University Graduate School of Medicine, Osaka - Japan
    (2) Department of Urology, Osaka City University Graduate School of Medicine, Osaka – Japan

  • Choroidopathy in patients with systemic lupus erythematosus with or without nephropathy

    Veronica Baglio1, Magda Gharbiya2, Corrado Balacco-Gabrieli3, Tommaso Mascaro2, Concetta Gangemi1, Manuela Di Franco4, Valentina Pistolesi1, Santo Morabito1, Gabriella Pecci1, Alessandro Pierucci1

    (1) Department of Clinical Sciences, Division of Nephrology, “Sapienza” University, Rome - Italy
    (2) Department of Ophthalmology, “Sapienza” University, Rome - Italy
    (3) Department of Ophthalmology, “Sapienza” University, Rome – Italy
    (4) Department of Rheumatology, “Sapienza” University, Rome - Italy

  • Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case

    Maria Concetta Postorino1, Marianna Bellantoni1, Concetta Catalano1, Graziella Caridi1, Marta De Rosa2, Sidy Seck3, Giuseppe Enia1

    (1) Nephrology, Hypertension and Renal Transplantation Unit, CNR-IBIM Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria - Italy
    (2) Unit of Microbiology and Virology Ospedali Riuniti, ?Reggio Calabria - Italy
    (3) Nephrology Department, University Hospital Aristide ?Le Dantec, Dakar - Senegal

Per supporto ed assistenza:
Segreteria Società Italiana di Nefrologia
Tel. 06.4465270 – nefrologia@sin-italy.org

© 2014-2017 Società Italiana di Nefrologia. Tutti i diritti riservati.
Realizzazione: TESISQUARE®
Cookie Policy

Per accedere ai contenuti occorre essere registrati ed avere effettuato la login.
Se non lo sei ancora, puoi registrarti a partire da questo link.

×